Impact of CYP2D6 polymorphism on plasma levels of donepezil: clinical relevance in patients with Alzheimer's disease

Research output: Contribution to conference › Paper › peer-review

Original language	English
Pages	207-207
Number of pages	1
Publication status	Published - 1 Jan 2004
Event	19th Eur.Work.Drug Metab. - Duration: 1 Jan 2004 → …

Conference	19th Eur.Work.Drug Metab.
Period	1/01/04 → …

Cite this

@conference{d262409b58c14077a80c6bcc4d83b7b8,

title = "Impact of CYP2D6 polymorphism on plasma levels of donepezil: clinical relevance in patients with Alzheimer's disease",

author = "SCORDO, \{M. G.\} and F. VARSALDI and G. MIGLIO and VILLA, \{M. L.\} and A. BIOLCATI and DAHL, \{M. L.\} and Grazia LOMBARDI",

year = "2004",

month = jan,

day = "1",

language = "English",

pages = "207--207",

note = "19th Eur.Work.Drug Metab. ; Conference date: 01-01-2004",

}

TY - CONF

T1 - Impact of CYP2D6 polymorphism on plasma levels of donepezil: clinical relevance in patients with Alzheimer's disease

AU - SCORDO, M. G.

AU - VARSALDI, F.

AU - MIGLIO, G.

AU - VILLA, M. L.

AU - BIOLCATI, A.

AU - DAHL, M. L.

AU - LOMBARDI, Grazia

PY - 2004/1/1

Y1 - 2004/1/1

UR - https://iris.uniupo.it/handle/11579/17145

M3 - Paper

SP - 207

EP - 207

T2 - 19th Eur.Work.Drug Metab.

Y2 - 1 January 2004

ER -